Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke

Abstract Oxidative stress is one of the main mechanisms implicated in the pathophysiology of inflammatory and neurodegenerative diseases of the central nervous system (CNS). Uric acid (UA) is the end product of purine catabolism in humans, and it is the main endogenous antioxidant in blood. Low circulating UA levels have been associated with an increased prevalence and worse clinical course of several neurodegenerative and inflammatory diseases of the CNS, including Parkinson’s disease and multiple sclerosis. Moreover, the exogenous administration of UA exerts robust neuroprotective properties in experimental models of CNS disease, including brain ischemia, spinal cord injury, meningitis, and experimental allergic encephalitis. In experimental brain ischemia, exogenous UA and the thrombolytic agent alteplase exert additive neuroprotective effects when administered in combination. UA is rapidly consumed following acute ischemic stroke, and higher UA levels at stroke admission are associated with a better outcome and reduced infarct growth at follow-up. A recent phase II trial demonstrated that the combined intravenous administration of UA and alteplase is safe and prevents an early decrease of circulating UA levels in acute ischemic stroke patients. Moreover, UA prevents the increase in the circulating levels of the lipid peroxidation marker malondialdehyde and of active matrix metalloproteinase (MMP) 9, a marker of blood–brain barrier disruption. The mod...
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research

Related Links:

Publication date: Available online 5 April 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Emmanuelle Waubant, Anne-Katrin Pröbstel, Michael Levy, Chris Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, Helen Tremlett
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 5 April 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Edgar Carnero Contentti, Jorge Correa
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Ischemic stroke damages the blood-brain barrier (BBB), which leads to brain edema and increases the risk of intracranial hemorrhage. Proteasome inhibition has been found to protect the BBB against cerebral ischemia by suppressing neuroinflammation-mediated matrix metalloproteases-9 (MMP-9) activation. We recently showed that ginsenoside Rd (Rd), a major active ingredient of Panax ginseng, could suppress proteasome-mediated inflammation and be efficient for treating ischemic stroke but downstream mechanisms were still unidentified. For this purpose, Sprague–Dawley rats were subjected to focal cerebral ischemic injury....
Source: NeuroReport - Category: Neurology Tags: Cellular, Molecular and Developmental Neuroscience Source Type: research
Source: BMJ News - Category: General Medicine Source Type: research
Authors: Şahin DG, Akay OM, Uskudar Teke H, Andıc N, Gunduz E Abstract Chronic myeloproliferative neoplasms (MPN) are clonal disorders of hematopoietic stem/progenitor cell characterized by thrombohemorrhagic complications and a tendency to transform into acute leukemia. The pathogenesis of thrombosis in MPN is complex and results from a multifaceted interplay of clinical and disease-related factors. Rotational thromboelastometry (ROTEM) provides the complete and rapid information about all stages of the coagulation process. Here, we assess ROTEM parameters as a screening of coagulation profile in patients with M...
Source: Platelets - Category: Hematology Tags: Platelets Source Type: research
AbstractThe utility of abdominal aortic calcification (AAC) for prediction of cardiovascular events (CVEs) in patients with acute coronary syndrome (ACS) remains to be determined. The aim of this prospective study was to determine the predictive value of the abdominal aortic calcification index (ACI), a semi-quantitative measure of AAC, for CVEs in patients with ACS. We evaluated 314 patients with ACS. All patients underwent successful percutaneous coronary intervention to the culprit coronary vessel without in-hospital adverse events. ACI was calculated on non-contrast computed tomography images. CVEs were defined as a co...
Source: Heart and Vessels - Category: Cardiology Source Type: research
A 58-year-old woman with COVID-19 and altered mental state was diagnosed with acute necrotizing encephalopathy.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Authors: Bielefeld V, Assad S, Guguen C, Goupil F, Le Meur G, Lebranchu P, Laballe R PMID: 32245580 [PubMed - as supplied by publisher]
Source: Journal Francais d Ophtalmologie - Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research
Conditions:   COVID;   Acute Coronary Syndrome;   Myocardial Infarction;   Myocarditis;   Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism Intervention:   Sponsor:   Centre Hospitalier Universitaire de Nice Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Stroke Interventions:   Device: Robotic group (Upper extremity robot-assisted training plus routine physical and rehabilitation medicine program);   Behavioral: Control group (routine physical and rehabilitation medicine program) Sponsor:   Ankara University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Activase | Allergy & Immunology | Brain | Clinical Trials | Emergency Medicine | Encephalitis | Ischemic Stroke | Men | Meningitis | Multiple Sclerosis | Neurology | Neuroscience | Spinal Cord Injury | Stroke | Thrombolytic Therapy | Thrombosis